Subscribe to Newsletter

Rodger Novak

The Power List 2020 – Advanced Medicine

Co-Founder and President at CRISPR Therapeutics

Rodger is one of the three co-founders of CRISPR Therapeutics, which aims to treat diseases using CRISPR/Cas9 gene editing technology. In 2019, the company announced positive interim safety and efficacy data in their ongoing CTX001 clinical trials, a CRISPR/Cas9 therapy for β-thalassemia and sickle cell disease, as well as advancing their first allogeneic CAR T cell therapy targeting CD19+ malignancies.

Part of the Power List 2020

The Power List 2020

Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.

Go to The Power List 2020

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine